Mitochondrial dysfunction following perinatal exposure to nucleoside analogues.
Blanche
Stéphane
S
Unité d'Immunologie Hématologie pédiatrique, Hôpital Necker Enfants-Malades, Assistance Subligne-Hopitaux de Paris et EA 3620 Université Paris 5, 149 Rue de Sèvres, 75015 Paris, France. blanche@necker.fr
Tardieu
Marc
M
Benhammou
Valérie
V
Warszawski
Josiane
J
Rustin
Pierre
P
D019380:Anti-HIV Agents / Q000009:adverse effects*; D002648:Child; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D015497:HIV-1; D006801:Humans; D007231:Infant, Newborn; D019259:Lamivudine / Q000009:adverse effects; D028361:Mitochondrial Diseases / Q000139:chemically induced* / Q000175:diagnosis; D009422:Nervous System Diseases / Q000139:chemically induced; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D011297:Prenatal Exposure Delayed Effects; D015215:Zidovudine / Q000009:adverse effects
D019380:Anti-HIV Agents; D019259:Lamivudine; D015215:Zidovudine